PDLIM7 and neoplasm: In conclusion, in this study we combined chemotherapy and antibody targeted therapy to show that MMC and anti-LMP1 Fab combination exhibited synergistic effects to inhibit NPC tumor growth in vivo with high efficacy and much less toxicity associated with MMC.